Triple helix formation between duplex DNA and oligonucleotides has been observed for over twenty years for synthetic polymers and more recently for genomic DNA. Triplex formation prevents the association of proteins with DNA, including transcription factors and RNA polymerase. Triple helix formation at the promoter or within a structural gene has been shown to repress transcription, and cells growing in culture have been shown to take up single stranded oligonucleotides through the cell membrane. Further, uptake of triple helix-forming oligonucleotides directed against transfected promoter-reporter gene constructs has repressed transcription of reporter gene in cultured cells. We propose to use triple helix formation to repress the transcription of progesterone receptor. As progesterone is one of a family of steroid hormones important in breast tissue growth and development, and as other strategies of progesterone receptor repression have proven effective against some breast cancers, we believe this approach has potential therapeutic value against breast cancer.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Small Business Innovation Research Grants (SBIR) - Phase I (R43)
Project #
1R43CA061434-01
Application #
3493485
Study Section
Special Emphasis Panel (ZRG7-SSS-Z (05))
Project Start
1993-08-04
Project End
1994-01-31
Budget Start
1993-08-04
Budget End
1994-01-31
Support Year
1
Fiscal Year
1993
Total Cost
Indirect Cost
Name
Triplex Pharmaceutical Corporation
Department
Type
DUNS #
City
The Woodlands
State
TX
Country
United States
Zip Code
77380